Triggering with GnRH agonist in oocyte-donation cycles: oestradiol monitoring is not necessary during ovarian stimulation
JC Castillo, M Dolz, J Moreno, L Gijón, R Ferrer… - Reproductive …, 2012 - Elsevier
This prospective observational study evaluated the efficacy and safety of oocyte-donation
cycles triggered with a gonadotrophin-releasing hormone (GnRH) agonist without
monitoring oestradiol concentrations during ovarian stimulation. A total of 97 oocyte donors
received recombinant FSH (150–225/day) and GnRH antagonists (0.25 mg/day). Oocyte
maturation was triggered with 0.2 mg triptorelin sc Donors aged 25.4±4.1 years were
stimulated for 8.8±0.9 days and underwent 2.9±0.5 (2–4) ultrasound assessments. Total …
cycles triggered with a gonadotrophin-releasing hormone (GnRH) agonist without
monitoring oestradiol concentrations during ovarian stimulation. A total of 97 oocyte donors
received recombinant FSH (150–225/day) and GnRH antagonists (0.25 mg/day). Oocyte
maturation was triggered with 0.2 mg triptorelin sc Donors aged 25.4±4.1 years were
stimulated for 8.8±0.9 days and underwent 2.9±0.5 (2–4) ultrasound assessments. Total …
以上显示的是最相近的搜索结果。 查看全部搜索结果